Pfizer (United States)-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2017

  1. Model description language (MDL): A standard for modeling and simulation

    CPT: Pharmacometrics and Systems Pharmacology, Vol. 6, Núm. 10, pp. 647-650

2009

  1. Modelling overdispersion and markovian features in count data

    Journal of Pharmacokinetics and Pharmacodynamics, Vol. 36, Núm. 5, pp. 461-477

2006

  1. Lack of localization of 5-HT6 receptors on cholinergic neurons: Implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release

    European Journal of Neuroscience, Vol. 24, Núm. 5, pp. 1299-1306

2000

  1. New antiherpetic 1,3-phenylene derivatives, inhibitors of the interaction of the HSV-1 origin binding protein (OBP) with DNA

    Drug Design and Discovery, Vol. 16, Núm. 4, pp. 295-315